Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bristol-Myers-Squibb
Company Monitoring Page for Bristol-Myers-Squibb
latest headlines for company on cafepharma
Merck to pony up $625M plus Keytruda royalties to settle BMS, Ono patent fight
Fierce Pharma
Tue, 06/13/23 - 10:49 pm
Tags:
Merck
,
Keytruda
,
Bristol Myers Squibb
,
Ono
,
patents
This Drug Candidate Could Be a Winner for Bristol Myers
Motley Fool
Mon, 06/12/23 - 10:18 am
Tags:
Bristol Myers Squibb
,
repotrectinib
,
non-small cell lung cancer
,
metastatic small cell lung cancer
ASCO: Seagen's top-selling drug under threat as Bristol Myers' Opdivo beats Adcetris in lymphoma
Fierce Pharma
Sun, 06/4/23 - 04:31 pm
Tags:
ASCO 2023 - Seagen
,
Bristol Myers Squibb
,
Adcetris
,
Opdivo
,
antibody-drug conjugate
,
Hodgkin's lymphoma
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
BioSpace
Wed, 05/31/23 - 11:15 am
Tags:
layoffs
,
Rain Oncology
,
Takeda
,
PTC Therapeutics
,
Affimed
,
Urovant Sciences
,
Roche
,
Novavax
,
Gossamer Bio
,
Bristol Myers Squibb
,
ADC Therapeutics
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA
,
Albireo Pharma
,
Aldeyra Therapeutics
,
Alvotech
,
Amneal Pharmaceuticals
,
Argenx
,
ARS Pharmaceuticals
,
AstraZeneca
,
Bayer
,
Bio-Thera Solutions
,
Biogen
,
BioMarin Pharmaceutical
,
Bristol Myers Squibb
,
Eisai
,
Eton Pharmaceuticals
,
F2G
,
Fabre-Kramer Pharmaceuticals
,
Fresenius
,
GSK
,
Intercept Pharmaceuticals
,
Ipsen
,
Ironwood Pharmaceuticals
,
Merck
,
Novaliq
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Takeda
,
Teva Pharmaceutica
,
UCB Pharma
ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?
Fierce Pharma
Fri, 05/26/23 - 09:57 am
Tags:
ASCO 2023
,
Bristol Myers Squibb
,
Breyanzi
,
CAR-T
,
CLL
,
SLL
,
clinical trials
Bristol Myers data make case for earlier use of bone marrow disease drug
BioPharma Dive
Thu, 05/25/23 - 08:31 pm
Tags:
Bristol Myers Squibb
,
Reblozyl
,
Epogen
,
myelodysplastic syndromes
,
clinical trials
Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug reduces lung function decline
Fierce Biotech
Tue, 05/23/23 - 06:12 pm
Tags:
Bristol Myers Squibb
,
clinical trials
,
BMS-986278
,
idiopathic pulmonary fibrosis
Big Pharma layoffs: BMS, Roche and Takeda axe hundreds of jobs
Medical Marketing and Media
Mon, 05/15/23 - 10:04 am
Tags:
layoffs
,
Bristol Myers Squibb
,
Roche
,
Takeda
,
Gossamer Bio
,
Novavax
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
Tags:
FDA
,
drug approvals
,
accelerated approvals
,
AbbVie
,
AstraZeneca
,
Bayer
,
Bristol Myers Squibb
,
JNJ
,
Merck
,
Merck KGaA
,
Novartis
,
Pfizer
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie
,
Amgen
,
AstraZeneca
,
Bristol Myers Squibb
,
Daiichi Sankyo
,
Eli Lilly
,
Gilead Sciences
,
Horizon Therapeutics
,
Merck
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model
BioSpace
Mon, 05/8/23 - 10:48 am
Tags:
Bristol Myers Squibb
,
layoffs
,
R&D
,
New Jersey
Biopharma Bets Big on Antibody-Drug Conjugates
BioSpace
Mon, 05/8/23 - 10:20 am
Tags:
antibody-drug conjugate
,
Merck
,
Seagen
,
M&A
,
AstraZeneca
,
BioNTech
,
Bristol Myers Squibb
Bristol Myers accuses AstraZeneca of infringing patent on cancer blockbuster Opdivo—again
Fierce Pharma
Tue, 05/2/23 - 11:29 pm
Tags:
Bristol Myers Squibb
,
Opdivo
,
patents
,
legal
,
AstraZeneca
AbbVie, Bristol Myers vied for Prometheus before Merck bought it
Crain's Chicago Business
Mon, 05/1/23 - 10:15 pm
Tags:
Merck
,
Prometheus Biosciences
,
M&A
,
AbbVie
,
Bristol Myers Squibb
FDA Accepts sBLA of BMS' Reblozyl
Targeted Oncology
Mon, 05/1/23 - 10:01 pm
Tags:
Bristol Myers Squibb
,
Reblozyl
,
FDA
,
MDS
,
anemia
Bristol Myers CEO Caforio steps down
Yahoo/Reuters
Wed, 04/26/23 - 05:55 pm
Tags:
Bristol Myers Squibb
,
Pharma CEOs
,
Giovanni Caforio
,
Christopher Boerner
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
Tags:
AbbVie
,
Amgen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sceinces
,
JNJ
,
Merck
,
Pfizer
,
Regeneron
,
patents
,
activists
Bristol Myers boosts cell therapy production with Novartis plant
BioPharma Dive
Wed, 04/26/23 - 05:40 pm
Tags:
Bristol Myers Squibb
,
cell therapy
,
Novartis
,
drug manufacturing
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D
,
AbbVie
,
Amgen
,
AstraZeneca
,
Bayer
,
Biogen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sciences
,
GSK
,
JNJ
,
Merck
,
Merck KGaA
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
UCB
,
Vertex Pharmaceuticals
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.